Healthpeak Properties Inc DOC.N, DOC is expected to show a fall in quarterly revenue when it reports results on October 23 for the period ending September 30 2025
The Denver Colorado-based company is expected to report a 1.1% decrease in revenue to $692.385 million from $700.4 million a year ago, according to the mean estimate from 9 analysts, based on LSEG data.
LSEG's mean analyst estimate for Healthpeak Properties Inc is for earnings of 6 cents per share.
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 13 "strong buy" or "buy," 7 "hold" and no "sell" or "strong sell."
The mean earnings estimate of analysts was unchanged in the last three months.
Wall Street's median 12-month price target for Healthpeak Properties Inc is $21.00, about 10.9% above its last closing price of $18.72
Previous quarterly performance (using preferred earnings measure in US dollars).
QUARTER ENDING | STARMINESMARTESTIMATE® | LSEG IBES ESTIMATE | ACTUAL | BEAT, MET, MISSED | SURPRISE % |
Jun. 30 2025 | 0.46 | 0.46 | 0.46 | Met | 1 |
Mar. 31 2025 | 0.46 | 0.46 | 0.46 | Met | 0.4 |
Dec. 31 2024 | 0.45 | 0.45 | 0.46 | Beat | 2.1 |
Sep. 30 2024 | 0.44 | 0.44 | 0.45 | Beat | 1.9 |
Jun. 30 2024 | 0.44 | 0.44 | 0.45 | Beat | 3 |
Mar. 31 2024 | 0.44 | 0.44 | 0.45 | Beat | 2.7 |
Dec. 31 2023 | 0.45 | 0.45 | 0.46 | Beat | 2.5 |
Sep. 30 2023 | 0.44 | 0.44 | 0.45 | Beat | 2.1 |
This summary was machine generated October 21 at 20:08 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)